89bio
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of 89bio generated cash of -$129,186,000, which is less than the previous year. Cash used in financing activities reached the amount of $513,111,000 last year. Net change in cash is therefore $260,906,000.
Cash Flow
| 2018 | -12.46M | -39K | 23.76M |
|---|---|---|---|
| 2019 | -25.46M | -139K | 107.70M |
| 2020 | -46.24M | -106.83M | 157.92M |
| 2021 | -76.78M | 7.15M | 23.87M |
| 2022 | -81.09M | -33.94M | 117.83M |
| 2023 | -129.18M | -123.01M | 513.11M |
ETNB Cash Flow Statement (2018 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 55.25M | 52.45M | 98.20M | 93.36M | 11.25M | 0 |
Operating activities | ||||||
Net income | -142.18M | -102.02M | -90.12M | -49.49M | -57.42M | -16.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 50K | 65K | 79K | 60K | 17K | 6K |
Stock-based compensation expense | 16.10M | 10.35M | 8.67M | 3.80M | 389K | 108K |
| Deferred income tax benefit | 16.10M | 10.35M | 8.67M | 3.80M | 389K | 108K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -3.91M | 5.65M | 4.77M | 1.13M | -520K | 1.50M |
Cash generated by operating activities | -129.18M | -81.09M | -76.78M | -46.24M | -25.46M | -12.46M |
Investing activities | ||||||
Purchases Of Investments | -341.14M | -152.69M | -141.2M | -118.89M | 0 | 0 |
Investments In Property Plant And Equipment | -4K | -7K | -63K | -126K | -139K | -39K |
Acquisitions Net | 0 | 33.93K | -7.22K | 106.70K | 0 | 0 |
Cash generated by investing activities | -123.01M | -33.94M | 7.15M | -106.83M | -139K | -39K |
Financing activities | ||||||
Common Stock Issued | 496.56M | 116.99M | 3.92M | 157.68M | 87.70M | 23.66M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 268K | 0 | 0 | 134K | 0 | 0 |
Repayments of term debt | 2.96M | 0 | -19.95M | 0 | 0 | -100K |
Cash used in financing activities | 513.11M | 117.83M | 23.87M | 157.92M | 107.70M | 23.76M |
Net Change In Cash | 260.90M | 2.79M | -45.75M | 4.84M | 82.10M | 11.25M |
Cash at end of period | 316.16M | 55.25M | 52.45M | 98.20M | 93.36M | 11.25M |
| Data source | Data source | Data source | Data source | Data source |